All News
Filter News
Found 808,979 articles
-
Tempest to Present at Two Upcoming Investor Conferences in November
11/9/2021
Tempest Therapeutics, Inc. today announced that management will present at the following investor conferences in November: Jefferies London Healthcare Conference – Company presentation available on-demand Thursday, November 18, 2021 at 8:00 a.m. GMT
-
Mereo BioPharma to Present at Two Upcoming Investor Conferences
11/9/2021
Mereo BioPharma Group plc today announced that Dr. Denise Scots-Knight, Chief Executive Officer of Mereo, will present at two upcoming investor conferences: Jefferies London Healthcare Conference In-person Fireside Chat, Wednesday, November 17 at 10:00 a.m. Greenwich Mean Time
-
Dentsply Sirona to Present at Upcoming Virtual Investor Conferences
11/9/2021
DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) - announced today that the Company will present at three upcoming investor conferences.
-
New Analysis to be Presented at the American Heart Association Scientific Sessions 2021 Evaluating Cardiovascular Benefits Across Baseline Kidney Function
11/9/2021
Lexicon Pharmaceuticals, Inc. today announced that a new analysis of sotagliflozin results from the SOLOIST and SCORED Phase 3 outcomes studies will be presented at the virtual American Heart Association Scientific Sessions 2021.
-
Humacyte Leadership to Present at Credit Suisse 30th Annual Healthcare Conference
11/9/2021
Humacyte, Inc. today announced that Laura Niklason, M.D., Ph.D., Chief Executive Officer, will present at the Credit Suisse 30th Annual Healthcare Conference taking place virtually, on Nov. 10, 2021, at 1 p.m. EST.
-
Vivos Therapeutics Schedules Third Quarter 2021 Financial Results Conference CallCall Scheduled for Monday, November 15, 2021 at 5:00 pm ET
11/9/2021
Vivos Therapeutics, Inc. today announced that it plans to release financial results for the third quarter ended September 30, 2021 after market close on Monday, November 15, 2021.
-
Aadi Bioscience to Participate in Upcoming Investor Conferences
11/9/2021
Aadi Bioscience, Inc. today announced that management will be participating in the upcoming Jefferies London Healthcare Conference and the Piper Sandler Virtual Healthcare Conference.
-
Alterity Therapeutics Announces Presentation of ATH434 at the American Autonomic Society Virtual Meeting 2021
11/9/2021
Alterity Therapeutics today announced a poster presentation and accompanying video were delivered at the American Autonomic Society 32nd Annual Internation Symposium
-
Agenus to Participate in Fireside Chat at the B. Riley Fall 2021 Growth Biotech Best Ideas Series
11/9/2021
Agenus Inc. today announced that Dr. Steven O’Day, Chief Medical Officer, and Dr. Dhan Chand, Scientific Director, Head of Drug Discovery at Agenus, will participate in a fireside chat hosted by B. Riley on Monday, November 15, 2021 at 12:00 PM EST.
-
Trevi Therapeutics to Present at Stifel 2021 Virtual Healthcare Conference
11/9/2021
Trevi Therapeutics, Inc. today announced that senior leadership members will participate in a virtual fireside chat, as well as host investor meetings, at the Stifel 2021 Virtual Healthcare Conference on November 15, 2021.
-
Neoleukin Therapeutics to Present at Upcoming Investor Conferences
11/9/2021
Neoleukin Therapeutics, Inc., today announced that management will participate in two upcoming investor conferences. Presentation Details: Event: Stifel 2021 Virtual Healthcare Conference Date: Tuesday, November 16, 2021 Time: 3:20 to 3:50 p.m. EST
-
Rigel to Participate in Two Upcoming Investor Conferences
11/9/2021
Rigel Pharmaceuticals, Inc. today announced that Dean Schorno , the company's chief financial officer, will participate in the following virtual investor conferences in November: Jefferies Virtual London Healthcare Conference ( November 18-19, 2021 )
-
Jounce Therapeutics to Present at Upcoming Investor Conferences in November
11/9/2021
Jounce Therapeutics, Inc. today announced that company management will participate at the following upcoming investor conferences in November: 5th Annual Cowen IO Next Summit : Fireside chat on Monday, November 15, 2021 at 10:45 a.m. ET. 33rd Annual Piper Sandler Healthcare Conference
-
Frequency Therapeutics Holds Virtual R&D Event Highlighting Clinical Advancement of FX-322, a New Potential Restorative Treatment for Hearing Loss and In Vivo Data for Its Remyelination Program in Multiple Sclerosis
11/9/2021
Frequency Therapeutics Holds Virtual R&D Event Highlighting Clinical Advancement of FX-322
-
Kane Biotech to Release Third Quarter 2021 Financial Results on November 16 – Conference Call to Follow
11/9/2021
Kane Biotech Inc. will announce its third quarter 2021 financial results after market close on Thursday, November 16, 2021.
-
9 Meters Biopharma, Inc. to Present at the 12th Annual Jefferies London Healthcare Conference
11/9/2021
9 Meters Biopharma, Inc. today announced that the Company's CEO, John Temperato is scheduled to present at the 12th Annual Jefferies London Healthcare Conference
-
ORYZON to Present New Clinical Data and Corporate Updates at International Conferences in November and December
11/9/2021
Oryzon Genomics, S.A. announced today that it will present new clinical data and present company updates at several renowned international conferences in November and December.
-
Aravive Announces Positive Preliminary Data from Phase 1b Trial Evaluating Batiraxcept (AVB-500) in Combination with Cabozantinib in Clear Cell Renal Cell Carcinoma to be Presented at 2021 Society for Immunotherapy of Cancer Annual Meeting
11/9/2021
Aravive, Inc. today announced that positive new data from the Phase 1b portion of its open-label Phase 1b/2 trial evaluating batiraxcept
-
Oncorus Announces Details of Upcoming ONCR-177 Phase 1 Initial Clinical Data Presentation at the Society for Immunotherapy of Cancer’s (SITC) 2021 Annual Meeting
11/9/2021
Oncorus, Inc. today announced details of its upcoming presentation of initial data from the ongoing Phase 1 dose escalation and expansion clinical trial of ONCR-177 at the upcoming Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting, taking place November 12–14, 2021 in Washington, D.C. and virtually.
-
Bruker Corporation to Participate in the 2021 Jefferies London Healthcare Conference
11/9/2021
Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 2021 Jefferies London Healthcare Conference.